1.
Shanshal AM, Aljorani RH, Hussain SA. Targeting IL-6 Signaling Pathways for Musculoskeletal Disorders Treatment: Risks and Benefits. Al-Rafidain J Med Sci [Internet]. 2023 Mar. 12 [cited 2024 Sep. 19];4:34-43. Available from: https://alhadhar.com/ajms/index.php/ALRAFIDAIN/article/view/101